← Eichor
Condition: Healthy Donors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Healthy Donors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT05628974A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Phase N/A · 1 location(s) · BioCytics, Inc. · NCT00571389Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Phase 3 · 4 location(s) · Center for International Blood and Marrow Transplant Researc · NCT00785525Transition From Donor Milk: a Feasibility Study
NA · 1 location(s) · Augusta University · NCT06514014Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research
NA · 1 location(s) · University Ghent · NCT06466707CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors
NA · 3 location(s) · First Affiliated Hospital of Zhejiang University · NCT07423728Lipid Characterisation of Plasma Microparticles in a Large Population of Healthy Donors
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT06183632A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Disease
Phase 1 · 28 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07115745Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Phase N/A · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT00001846Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC
Phase 2 · 1 location(s) · Diwakar Davar · NCT05669846Improving White Blood Cell Collection From Healthy Donors
Phase 4 · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT01553214Investigating the Impact of the Seaweed Derived Food Additive, Carrageenan, on the Human Gut Microbiome
NA · 1 location(s) · University of Reading · NCT06738329Collection of Data and Samples From Healthy Donors for Use in Translational Research
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00090662Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Phase N/A · 1 location(s) · Checkmab S.r.l. · NCT06842407Assessment of Risks of Perinephric Fat Thickness to Adverse Renal Outcomes Post Donor Nephrectomy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06886087Cytapheresis of Volunteer Donors
Phase N/A · 1 location(s) · National Institute on Aging (NIA) · NCT00104325Telemedicine to Support Living Kidney Donor Candidates
NA · 1 location(s) · University of California, Irvine · NCT07206069Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With
Phase N/A · 2 location(s) · Patrick Schjelderup · NCT06210555The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
Phase N/A · 2 location(s) · Linkoeping University · NCT06580639Collection of Stool From Healthy Donors for the ex Vivo Study of Shifts of Microbiome Induced by Dairy Phages and Antibi
Phase N/A · 1 location(s) · Institut National de Recherche pour l'Agriculture, l'Aliment · NCT07212400Non-invasive Preoperative Tissue Evaluation in Head and Neck Tumor Patients Using Multispectral Optoacoustic Tomography
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT06716892Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Im
Phase 2 · 1 location(s) · Diwakar Davar · NCT06499896Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001529Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06187870Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors
Phase 3 · 8 location(s) · First Affiliated Hospital of Zhejiang University · NCT07692841Healthy Stool Volunteer Donors for Fecal Microbiota Transplantation Trials
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06478823Blood Donor CVD 5000
Phase 4 · 1 location(s) · University of Maryland, Baltimore · NCT03971669
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.